217 related articles for article (PubMed ID: 31536817)
1. Anti-herpesvirus prophylaxis, pre-emptive treatment or no treatment in adults undergoing allogeneic transplant for haematological disease: systematic review and meta-analysis.
Beyar-Katz O; Bitterman R; Zuckerman T; Ofran Y; Yahav D; Paul M
Clin Microbiol Infect; 2020 Feb; 26(2):189-198. PubMed ID: 31536817
[TBL] [Abstract][Full Text] [Related]
2. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Vernooij RW; Michael M; Ladhani M; Webster AC; Strippoli GF; Craig JC; Hodson EM
Cochrane Database Syst Rev; 2024 May; 5(5):CD003774. PubMed ID: 38700045
[TBL] [Abstract][Full Text] [Related]
3. Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.
Strippoli GF; Hodson EM; Jones CJ; Craig JC
Cochrane Database Syst Rev; 2006 Jan; (1):CD005133. PubMed ID: 16437521
[TBL] [Abstract][Full Text] [Related]
4. Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.
Owers DS; Webster AC; Strippoli GF; Kable K; Hodson EM
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD005133. PubMed ID: 23450558
[TBL] [Abstract][Full Text] [Related]
5. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Hodson EM; Ladhani M; Webster AC; Strippoli GF; Craig JC
Cochrane Database Syst Rev; 2013 Feb; (2):CD003774. PubMed ID: 23450543
[TBL] [Abstract][Full Text] [Related]
6. Antiviral prophylaxis in haematological patients: systematic review and meta-analysis.
Yahav D; Gafter-Gvili A; Muchtar E; Skalsky K; Kariv G; Yeshurun M; Leibovici L; Paul M
Eur J Cancer; 2009 Dec; 45(18):3131-48. PubMed ID: 19796930
[TBL] [Abstract][Full Text] [Related]
7. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Hodson EM; Barclay PG; Craig JC; Jones C; Kable K; Strippoli GF; Vimalachandra D; Webster AC
Cochrane Database Syst Rev; 2005 Oct; (4):CD003774. PubMed ID: 16235341
[TBL] [Abstract][Full Text] [Related]
8. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Hodson EM; Craig JC; Strippoli GF; Webster AC
Cochrane Database Syst Rev; 2008 Apr; (2):CD003774. PubMed ID: 18425894
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients.
Hodson EM; Jones CA; Strippoli GF; Webster AC; Craig JC
Cochrane Database Syst Rev; 2007 Apr; (2):CD005129. PubMed ID: 17443573
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of acyclovir prophylaxis against varicella zoster virus disease after allogeneic hematopoietic cell transplantation: A systematic review and meta-analysis.
Wada-Shimosato Y; Tanoshima R; Hiratoko K; Takeuchi M; Tsujimoto SI; Shiba N; Ito S; Yamanaka T; Ito S
Transpl Infect Dis; 2019 Jun; 21(3):e13061. PubMed ID: 30756465
[TBL] [Abstract][Full Text] [Related]
11. Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation.
Chen K; Cheng MP; Hammond SP; Einsele H; Marty FM
Blood Adv; 2018 Aug; 2(16):2159-2175. PubMed ID: 30154125
[TBL] [Abstract][Full Text] [Related]
12. Prophylaxis against herpesvirus infections in transplant recipients.
Ljungman P
Drugs; 2001; 61(2):187-96. PubMed ID: 11270937
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis of herpesvirus infections in immunocompetent and immunocompromised older patients.
Fillet AM
Drugs Aging; 2002; 19(5):343-54. PubMed ID: 12093321
[TBL] [Abstract][Full Text] [Related]
14. Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients.
Ruiz-Camps I; Len O; de la Cámara R; Gurguí M; Martino R; Jarque I; Barrenetxea C; Díaz de Heredia C; Batlle M; Rovira M; de la Torre J; Torres A; Aguilar M; Espigado I; Martín-Dávila P; Bou G; Borrell N; Aguado JM; Pahissa A;
Antivir Ther; 2011; 16(7):951-7. PubMed ID: 22024510
[TBL] [Abstract][Full Text] [Related]
15. Viral prophylaxis in organ transplant patients.
Slifkin M; Doron S; Snydman DR
Drugs; 2004; 64(24):2763-92. PubMed ID: 15563248
[TBL] [Abstract][Full Text] [Related]
16. [Antiviral prophylaxis and pre-emptive therapy for the prevention of Cytomegalovirus infection in renal transplant recipients: guideline from the Italian Society of Nephrology].
Cornella C; Torazza MC; Strippoli GF; Segoloni G;
G Ital Nefrol; 2007; 24 Suppl 37():S165-78. PubMed ID: 17347963
[TBL] [Abstract][Full Text] [Related]
17. Impact of Prophylaxis vs Pre-emptive Approach for Cytomegalovirus Infection in Kidney Transplant Recipients.
Kır O; Zeytinoğlu A; Arda B; Yılmaz M; Aşçı G; Töz H
Transplant Proc; 2017 Apr; 49(3):537-540. PubMed ID: 28340829
[TBL] [Abstract][Full Text] [Related]
18. Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients.
Strippoli GF; Hodson EM; Jones C; Craig JC
Transplantation; 2006 Jan; 81(2):139-45. PubMed ID: 16436954
[TBL] [Abstract][Full Text] [Related]
19. Clinical and economic burden of pre-emptive therapy of cytomegalovirus infection in hospitalized allogeneic hematopoietic cell transplant recipients.
El Haddad L; Ghantoji SS; Park AK; Batista MV; Schelfhout J; Hachem J; Lobo Y; Jiang Y; Rondon G; Champlin R; Chemaly RF
J Med Virol; 2020 Jan; 92(1):86-95. PubMed ID: 31448830
[TBL] [Abstract][Full Text] [Related]
20. A Systematic Review and Meta-analysis of Prophylactic versus Pre-emptive Strategies for Preventing Cytomegalovirus Infection in Renal Transplant Recipients.
Rawal BB; Shadrou S; Abubacker F; Ghahramani N
Int J Organ Transplant Med; 2012; 3(1):10-7. PubMed ID: 25013618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
